ARWR logo

ARWR Arrowhead Pharmaceuticals, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$43.65
+0.54 (+1.25%)

Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, …

Market Cap: $6.17Barrowheadpharma.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
42
5 mentions
—
60d
52
12 mentions
—
90d
50
29 mentions
—
news: 13 · rss: 14 · marketaux: 2

Analyst Ratings

22 analysts
Buyconsensus
Strong Buy 0Buy 16Hold 6Sell 0Strong Sell 0
Avg price target$111.2+154.8%
Low $74Median $117.5High $126
Current Consensus

Revenue

$37.79M+765.74%
$0.00$180.90M$361.81M$542.71M
Dec 2016Sep 2026

Analyst Estimates

FY2026
$-3.52
$-5.00–$-2.38
12 analysts
FY2027
$-5.47
$-8.81–$-2.91
12 analysts
FY2028
$-3.96
$-7.11–$0.15
9 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Christopher R. Anzalone
Sector
Healthcare
Industry
Biotechnology
Employees
1,059
Beta
1.37
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
0.01
arrowheadpharma.com